TRIM37 and neoplasm: After extensive quality control to remove cases with low tumor content and/or low sequencing coverage (see Methods), all 42 high-risk neuroblastomas showed evidence for 17q gain (37 with segmental 17q gain, 5 with whole chromosome 17 gain), with all but one sample showing gain at the TRIM37 locus (Figure 2A).